Literature DB >> 16611216

Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.

Etienne Tokonzaba1, Daniel G S Capelluto, Tatiana G Kutateladze, Michael Overduin.   

Abstract

Signaling proteins are localized and regulated by Src homology 2 domains which recognize phosphotyrosine-containing sequences. Recently, noncanonical ligands have been proposed for Src homology 2 domains including that of Abl and its breakpoint cluster region fusion, which causes chronic myelogenous leukemia. Here, the Abl Src homology 2 domain's binding sites and affinities for phosphotyrosine- and phosphoserine-containing motifs, phosphoinositides as well as a pyridone-based peptidomimetic inhibitor were determined using nuclear magnetic resonance spectroscopy in order to define their roles. The cognate Crk peptide ligand was bound with an affinity of 69 microM and, like the higher affinity peptidomimetic, engages the phosphotyrosine and +3 hydrophobic pockets while putative phosphoserine-containing breakpoint cluster region ligands are ruled out. Surprisingly, phosphatidylinositol 4, 5 bisphosphate interacts with an overlapping site through an electrostatic mechanism that does not appear to involve hydrophobic insertion into micelles. The conserved Arg36 residue in the FLVRES motif is required for both phosphotyrosine binding and for localization to phosphatidylinositol 4, 5 bisphosphate-containing liposomes, while Arg59 in the betaD strand is necessary for the phosphoinositide interaction. Thus the Src homology 2 domain of Abl, a myristoylated and membrane-localized protein, is able to interact directly with phosphoinositides through a multifunctional basic site that overlaps the phosphotyrosine pocket.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611216      PMCID: PMC2610419          DOI: 10.1111/j.1747-0285.2006.00361.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  39 in total

1.  A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.

Authors:  D Barilá; R Mangano; S Gonfloni; J Kretzschmar; M Moro; D Bohmann; G Superti-Furga
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Imatinib mesylate in cutaneous melanoma.

Authors:  Pedro Redondo; Pedro Lloret; Enrique J Andreu; Susana Inoges
Journal:  J Invest Dermatol       Date:  2004-12       Impact factor: 8.551

3.  Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain.

Authors:  I Joung; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.

Authors:  S Grzesiek; S J Stahl; P T Wingfield; A Bax
Journal:  Biochemistry       Date:  1996-08-13       Impact factor: 3.162

Review 6.  Strategies to overcome resistance to targeted protein kinase inhibitors.

Authors:  Henrik Daub; Katja Specht; Axel Ullrich
Journal:  Nat Rev Drug Discov       Date:  2004-12       Impact factor: 84.694

7.  Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins.

Authors:  L E Rameh; C S Chen; L C Cantley
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

8.  Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution.

Authors:  M Overduin; B Mayer; C B Rios; D Baltimore; D Cowburn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region.

Authors:  I Park; J Chung; C T Walsh; Y Yun; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

10.  Targeting of the FYVE domain to endosomal membranes is regulated by a histidine switch.

Authors:  Stephanie A Lee; Rosemary Eyeson; Matthew L Cheever; Jinming Geng; Vladislav V Verkhusha; Christopher Burd; Michael Overduin; Tatiana G Kutateladze
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

View more
  9 in total

1.  SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins.

Authors:  Mi-Jeong Park; Ren Sheng; Antonina Silkov; Da-Jung Jung; Zhi-Gang Wang; Yao Xin; Hyunjin Kim; Pallavi Thiagarajan-Rosenkranz; Seohyeon Song; Youngdae Yoon; Wonhee Nam; Ilshin Kim; Eui Kim; Dong-Gyu Lee; Yong Chen; Indira Singaram; Li Wang; Myoung Ho Jang; Cheol-Sang Hwang; Barry Honig; Sungho Ryu; Justin Lorieau; You-Me Kim; Wonhwa Cho
Journal:  Mol Cell       Date:  2016-03-24       Impact factor: 17.970

2.  c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.

Authors:  Nandini Ghosh-Choudhury; Chandi C Mandal; Falguni Das; Suthakar Ganapathy; Seema Ahuja; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2013-07-02       Impact factor: 5.157

Review 3.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

4.  EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.

Authors:  Rakshamani Tripathi; Zulong Liu; Rina Plattner
Journal:  Curr Pharmacol Rep       Date:  2018-07-23

5.  A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

Authors:  John Wojcik; Oliver Hantschel; Florian Grebien; Ines Kaupe; Keiryn L Bennett; John Barkinge; Richard B Jones; Akiko Koide; Giulio Superti-Furga; Shohei Koide
Journal:  Nat Struct Mol Biol       Date:  2010-03-28       Impact factor: 15.369

6.  Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding.

Authors:  Yoojin Hong; Dimitra Chalkia; Kyung Dae Ko; Gaurav Bhardwaj; Gue Su Chang; Damian B van Rossum; Randen L Patterson
Journal:  J Proteomics Bioinform       Date:  2009-03-21

7.  Lipids Regulate Lck Protein Activity through Their Interactions with the Lck Src Homology 2 Domain.

Authors:  Ren Sheng; Da-Jung Jung; Antonina Silkov; Hyunjin Kim; Indira Singaram; Zhi-Gang Wang; Yao Xin; Eui Kim; Mi-Jeong Park; Pallavi Thiagarajan-Rosenkranz; Sean Smrt; Barry Honig; Kwanghee Baek; Sungho Ryu; Justin Lorieau; You-Me Kim; Wonhwa Cho
Journal:  J Biol Chem       Date:  2016-06-22       Impact factor: 5.157

Review 8.  Novel Roles of SH2 and SH3 Domains in Lipid Binding.

Authors:  Szabolcs Sipeki; Kitti Koprivanacz; Tamás Takács; Anita Kurilla; Loretta László; Virag Vas; László Buday
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

Review 9.  Motif mediated protein-protein interactions as drug targets.

Authors:  Carles Corbi-Verge; Philip M Kim
Journal:  Cell Commun Signal       Date:  2016-03-02       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.